Abstract
Pancreatic Ductal Adenocarcinoma (PDAC) is a highly aggressive malignant tumor, with patients showing a low life expectancy on a global scale. This unfavorable scenario is related to multivariable risk factors, nonspecific symptoms, late diagnosis, and, most importantly, the lack of effective therapeutic targets. Three-dimensional organoid models have emerged as an essential tool for stud…